Drug Trial Radar · NCT06893250
Orthobiologic Treatment for Knee Osteoarthritis
Last checked: Nov 19, 2026Latest source record: Jun 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
160
Planned (sponsor's estimate)
Start
Sep 23, 2024
Primary completion
Dec 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- University Hospital of North NorwayAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 25, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 40 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this randomized clinical trial is to compare treatment for osteoarthritis in the knee using platelet rich plasma (PRP) or adipose stem cells (ADS). The main questions it aims to answer are: * Will the patients clinically benefit from the treatment, and if so, which treatment is better? * Will there be radiological findings to support this? Participants will be randomized into one of four groups: PRP, ADS, PRP + ADS or placebo treatment (saline) and will be examined and get an X-ray and MRI of the knee taken at inclusion and after 1 and 2 years.
Conditions
- Osteoarthritis Knee
Interventions
PRP injectionBiological
Platelet rich plasma, blood from the patient that is centrifuged.
ADSTEM Inj. (Adult human mesenchymal stem cells)Biological
Adipose tissue stem cells, from abdominal fat.
InjectionBiological
PRP + adipose tissue stem cells
Saline (NaCl 0,9 %) (placebo)Biological
Sterile saline injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- KOOS (The Knee injury and Osteoarthritis Outcome Score)Time frame: Evaluated during 2 years of follow up (6 weeks, 12 weeks, 6 months, 1 year, 2 years)
- WOMAC score (Western Ontario og McMaster Universities Osteoarthritis Index)Time frame: Evaluated during 2 years of follow up (6 weeks, 12 weeks, 6 months, 1 year, 2 years)
- VAS (Visual analogue scale)Time frame: Evaluated during 2 years of follow up (6 weeks, 12 weeks, 6 months, 1 year, 2 years)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University Hospital in Northern Norway
Tromsø, Tromsø, Norway
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.